Hong Kong stocks surged|Hansai Aitai-B (03378.HK) rebounded by nearly 6%, innovative drug HX111 received approval from the National Medical Products Administration for clinical trials.
According to the AI Finance app, Hansartai -B (03378.HK) has rebounded by nearly 6%, as of press time, it is up 5.12%, trading at HK$18.08, with a turnover of HK$10.48 million.
Latest
